A Study of CS1001 in Subjects with Advanced Solid Tumors
Clinical trial NCT03744403 · COMPLETED
Trial details
- NCT number
- NCT03744403
- Sponsor
- CStone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-04
- Primary completion
- 2020-10-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.